bioRxivGeneticsPreprint
Common variants associated with OSMR expression contribute to carotid plaque vulnerability, but not to cardiovascular disease in humans
D. van KeuleniD, Ian D. van KoeverdeniD, Arjan BoltjesiD, H.M.G. PrinceniD, A.J. van GooliD, Gert Jan de BorstiD, Folkert Wouter AsselbergsiD, Dennie TempeliD, Gerard PasterkampiD, Sander W. van der LaaniD
Abstract
Background and aimsOncostatin M (OSM) signaling is implicated in atherosclerosis, however the mechanism remains unclear. We investigated the impact of common genetic variants in OSM and its receptors, OSMR and LIFR, on overall plaque vulnerability, plaque phenotype, intraplaque OSMR and LIFR expression, coronary artery calcification burden and cardiovascular disease susceptibility. Methods and resultsWe queried Genotype-Tissue Expression data and found that rs13168867 (C allele) was associated with decreased OSMR expression and that rs10491509 (A allele) was associated with increased LIFR expression in arterial tissues. No variant was significantly associated with OSM expression. We associated these two variants with plaque characteristics from 1,443 genotyped carotid endarterectomy patients in the Athero-Express Biobank Study. After correction for multiple testing, rs13168867 was significantly associated with an increased overall plaque vulnerability ({beta}=0.118 {+/-} s.e.=0.040, p=3.00x10-3, C allele). Looking at individual plaque characteristics, rs13168867 showed strongest associations with intraplaque fat ({beta}=0.248 {+/-} s.e.=0.088, p=4.66 x 10-3, C allele) and collagen content ({beta}=-0.259 {+/-} s.e.=0.095, p=6.22 x 10-3, C allele), but these associations were not significant after correction for multiple testing. rs13168867 was not associated with intraplaque OSMR expression. Neither was intraplaque OSMR expression associated with plaque vulnerability and no known OSMR eQTLs were associated with coronary artery calcification burden, or cardiovascular disease susceptibility. No associations were found for rs10491509 in the LIFR locus. ConclusionsOur study suggests that rs1316887 in the OSMR locus is associated with increased plaque vulnerability, but not with coronary calcification or cardiovascular disease risk. It remains unclear through which precise biological mechanisms OSM signaling exerts its effects on plaque morphology. However, the OSM-OSMR/LIFR pathway is unlikely to be causally involved in lifetime cardiovascular disease susceptibility.
- organism: human
- assay: bulk RNA-seq
- research focus: GWAS / association mapping
- approach: statistical model
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Genetic and atherosclerotic plaque immunohistochemical analyses do not associate reduced sclerostin expression with cardiovascular events
Gill Holdsworth, James R Staley, … Gerard Pasterkamp·Journal of Bone and Mineral ResearchPeer-reviewed·Dec 1, 2020
- Polygenic Risk Score Associates with Atherosclerotic Plaque Characteristics at Autopsy
Anne Cornelissen, Neel V. Gadhoke, … Aloke Virmani Finn·Arteriosclerosis Thrombosis and Vascular BiologyPeer-reviewed·Nov 2, 2023
- Genetic inhibition of PCSK9, atherogenic lipoprotein concentrations, and calcific aortic valve stenosis
Nicolas Perrot, Donato Moschetta, … Benoît J. Arsenault·bioRxiv·Mar 1, 2019
- A transcriptome-wide association study identifies PALMD as a susceptibility gene for calcific aortic valve stenosis
Sébastien Thériault, Nathalie Gaudreault, … Yohan Bossé·Nature CommunicationsPeer-reviewed·Mar 1, 2018
- Genetic association analyses highlight IL6, ALPL, and NAV1 as three new susceptibility genes underlying calcific aortic valve stenosis
Sébastien Thériault, Christian Dina C, … Sylviane Vol·Circulation Genomic and Precision MedicinePeer-reviewed·Oct 1, 2019
- SVEP1, a novel human coronary artery disease locus, promotes atherosclerosis
In‐Hyuk Jung, Jared S. Elenbaas, … Nathan O. Stitziel·Science Translational MedicinePeer-reviewed·Mar 24, 2021